(Q31162052)

23 September 2017

Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study (English)

1 reference

23 September 2017

0 references

Laura De Giglio

9

0 references

Alessandra Lugaresi

Alessandra Lugaresi

20

0 references

Maria Giovanna Marrosu

Maria Giovanna Marrosu

13

0 references

Maria Trojano

Maria Trojano

12

0 references

Maria Pia Amato

Maria Pia Amato

24

0 references

Giacomo P Comi

23

Giancarlo Comi

1 reference

23 September 2017

4

Angelo Ghezzi

1 reference

23 September 2017

21

Lucia Moiola

1 reference

23 September 2017

10

Carlo Pozzilli

1 reference

23 September 2017

22

Vittorio Martinelli

1 reference

23 September 2017

3

Emilio Portaccio

1 reference

23 September 2017

14

Francesco Patti

1 reference

23 September 2017

2

Marta Giannini

1 reference

23 September 2017

5

Bahia Hakiki

1 reference

23 September 2017

6

Luisa Pastò

1 reference

23 September 2017

7

Lorenzo Razzolini

1 reference

23 September 2017

8

Andrea Sturchio

1 reference

23 September 2017

11

Damiano Paolicelli

1 reference

23 September 2017

15

Gian Luigi Mancardi

1 reference

23 September 2017

17

Rocco Totaro

1 reference

23 September 2017

18

Maria Rosaria Tola

1 reference

MS Study Group of the Italian Neurological Society

23 September 2017

25

MS Study Group of the Italian Neurological Society

1 reference

23 September 2017

Chiara Pecori

1

1 reference

23 September 2017

Claudio Solaro

16

1 reference

23 September 2017

Giovanna De Luca

19

1 reference

23 September 2017

26 May 2014

1 reference

23 September 2017

1 reference

23 September 2017

14

1 reference

23 September 2017

114

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2377-14-114

23 September 2017

0 references

cites work

Birth outcomes in newborns fathered by men with multiple sclerosis exposed to disease-modifying drugs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059028

Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059028

Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059028

What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059028

Paternal exposure and counselling: Experience of a Teratology Information Service

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059028

Evidence for a role of paternal exposures in developmental toxicity

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059028

Cytokines and the immune-testicular axis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059028

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059028

Teratogen update: paternal exposures-reproductive risks

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059028

Mutagenicity studies of human fibroblast interferon (HuIFN-β)

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059028

Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis.

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-14-114

Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-14-114

A pilot study of paternal drug exposure: the Motherisk experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-14-114

Interferon alpha-2b may impair testicular histology including spermatogenesis in a rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-14-114

Parenthood and immunomodulation in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-14-114

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-14-114

Teratogen update: paternal exposures?reproductive risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-14-114

Birth outcomes of pregnancies fathered by men with multiple sclerosis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059028

Expression of alpha and gamma interferon receptors in the sperm cell

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24884599

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2377-14-114

1 reference

Dimensions Publication ID

23 September 2017

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1471-2377-14-114

1 reference

23 September 2017

PubMed publication ID

24884599

1 reference